Rating History for CymaBay Therapeutic (CBAY) by Leerink Partners
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/20/2024 | Thomas J. Smith | Downgrade | Market Perform (Outperform) |
32.50 (26.00) |
32.20 (32.48) |
0.87% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
